160 related articles for article (PubMed ID: 38700672)
1. A balanced perspective on bladder preservation and systemic treatment in muscle-invasive bladder cancer.
Lin FX; Wang L; Xu ZP
World J Urol; 2024 May; 42(1):288. PubMed ID: 38700672
[No Abstract] [Full Text] [Related]
2. Bladder sparing surgery in high-grade bladder cancer.
Yakovlev PG; Klyushin DA; Vereshchako RI
Exp Oncol; 2019 Jun; 41(2):160-165. PubMed ID: 31262149
[TBL] [Abstract][Full Text] [Related]
3. Bladder cancer: bladder preservation--learning what we don't know.
Hussain M; Theodorescu D
Nat Rev Urol; 2014 Jun; 11(6):310-2. PubMed ID: 24841166
[TBL] [Abstract][Full Text] [Related]
4. Bladder-sparing treatment options in localized muscle-invasive bladder cancer.
Nason GJ; Ajib K; Tan GH; Kulkarni GS
Expert Rev Anticancer Ther; 2020 Mar; 20(3):179-188. PubMed ID: 32129122
[No Abstract] [Full Text] [Related]
5. High Ki-67 Expression Predicts Favorable Survival in Muscle-Invasive Bladder Cancer Patients Treated With Chemoradiation-Based Bladder-Sparing Protocol.
Tanabe K; Yoshida S; Koga F; Inoue M; Kobayashi S; Ishioka J; Tamura T; Sugawara E; Saito K; Akashi T; Fujii Y; Kihara K
Clin Genitourin Cancer; 2015 Aug; 13(4):e243-e251. PubMed ID: 25936588
[TBL] [Abstract][Full Text] [Related]
6. [Comprehensive therapy of bladder preservation for muscle invasive bladder cancer].
Li B; Li Y
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2018 Jan; 43(1):82-89. PubMed ID: 30154296
[TBL] [Abstract][Full Text] [Related]
7. Trimodality Therapy for Muscle-Invasive Bladder Cancer: Recent Advances and Unanswered Questions.
Jiang DM; Chung P; Kulkarni GS; Sridhar SS
Curr Oncol Rep; 2020 Feb; 22(2):14. PubMed ID: 32008105
[TBL] [Abstract][Full Text] [Related]
8. Re: Katharina Brück, Richard P. Meijer, Joost L. Boormans, et al. Disease-free Survival of Patients with Muscle-invasive Bladder Cancer Treated with Radical Cystectomy Versus Bladder-preserving Therapy: A Nationwide Study. Int J Radiat Oncol Biol Phys. In press. https://doi.org/10.1016/j.ijrobp.2023.07.027.
Basile G; Pradere B; Lenfant L; Rouprêt M; Seisen T
Eur Urol Oncol; 2024 Jun; 7(3):637-638. PubMed ID: 37978023
[No Abstract] [Full Text] [Related]
9. Can bladder preservation therapy come to the center stage?
Inamoto T; Ibuki N; Komura K; Juri H; Yamamoto K; Yamamoto K; Fujita K; Nonomura N; Narumi Y; Azuma H
Int J Urol; 2018 Feb; 25(2):134-140. PubMed ID: 29171098
[TBL] [Abstract][Full Text] [Related]
10. Trimodal therapy for muscle-invasive bladder cancer.
Mathes J; Rausch S; Todenhöfer T; Stenzl A
Expert Rev Anticancer Ther; 2018 Dec; 18(12):1219-1229. PubMed ID: 30324833
[TBL] [Abstract][Full Text] [Related]
11. [Organ-sparing treatment of bladder cancer].
Niedworok C; Shaleva A; Rübben H; Stenzl A
Urologe A; 2016 May; 55(5):609-14. PubMed ID: 27119956
[TBL] [Abstract][Full Text] [Related]
12. Bladder Preserving Trimodality Therapy for Muscle-Invasive Bladder Cancer.
Johnson SB; Yu JB
Curr Oncol Rep; 2018 Jun; 20(9):66. PubMed ID: 29959582
[TBL] [Abstract][Full Text] [Related]
13. Trimodality bladder-sparing approach without neoadjuvant chemotherapy for node-negative localized muscle-invasive urinary bladder cancer resulted in comparable cystectomy-free survival.
Lee CY; Yang KL; Ko HL; Huang RY; Tsai PP; Chen MT; Lin YC; Hwang TI; Juang GD; Chi KH
Radiat Oncol; 2014 Sep; 9():213. PubMed ID: 25248470
[TBL] [Abstract][Full Text] [Related]
14. Critical analysis of bladder sparing with trimodal therapy in muscle-invasive bladder cancer: a systematic review.
Ploussard G; Daneshmand S; Efstathiou JA; Herr HW; James ND; Rödel CM; Shariat SF; Shipley WU; Sternberg CN; Thalmann GN; Kassouf W
Eur Urol; 2014 Jul; 66(1):120-37. PubMed ID: 24613684
[TBL] [Abstract][Full Text] [Related]
15. [Not Available].
Schilling D; Gakis G; Sievert KD; Stenzl A
Aktuelle Urol; 2015 Jan; 46(1):72-81. PubMed ID: 25658234
[No Abstract] [Full Text] [Related]
16. Bladder-sparing treatment of invasive bladder cancer.
Rivera I; Wajsman Z
Cancer Control; 2000; 7(4):340-6. PubMed ID: 10895128
[TBL] [Abstract][Full Text] [Related]
17. Bladder cancer.
Clark PE; Agarwal N; Biagioli MC; Eisenberger MA; Greenberg RE; Herr HW; Inman BA; Kuban DA; Kuzel TM; Lele SM; Michalski J; Pagliaro LC; Pal SK; Patterson A; Plimack ER; Pohar KS; Porter MP; Richie JP; Sexton WJ; Shipley WU; Small EJ; Spiess PE; Trump DL; Wile G; Wilson TG; Dwyer M; Ho M;
J Natl Compr Canc Netw; 2013 Apr; 11(4):446-75. PubMed ID: 23584347
[TBL] [Abstract][Full Text] [Related]
18. Chemoradiation for organ preservation in the treatment of muscle-invasive bladder cancer.
McHaffie DR; Kruser TJ; Gaston K; Mahoney J; Graham D; Haake M
Urol Oncol; 2016 Jun; 34(6):271-8. PubMed ID: 27108225
[TBL] [Abstract][Full Text] [Related]
19. Treatment of muscle-invasive bladder cancer: A systematic review.
Chou R; Selph SS; Buckley DI; Gustafson KS; Griffin JC; Grusing SE; Gore JL
Cancer; 2016 Mar; 122(6):842-51. PubMed ID: 26773572
[TBL] [Abstract][Full Text] [Related]
20. Bladder preservation in muscle-invasive bladder cancer: a comprehensive review.
Hamad J; McCloskey H; Milowsky MI; Royce T; Smith A
Int Braz J Urol; 2020; 46(2):169-184. PubMed ID: 31961624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]